Home > Journals > Medicine > European Journal of Dermatology > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
European Journal of Dermatology
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Allergen microarrays: a novel tool for high-resolution IgE profiling in adults with atopic dermatitis


European Journal of Dermatology. Volume 20, Number 1, 54-61, January-February 2010, Investigative report

Full Text  

Author(s) : Hagen Ott, Regina Fölster-Holst, Hans F Merk, Jens Malte Baron

Summary : Microarray technology has recently been introduced into clinical allergology, but its applicability in adult patients with atopic dermatitis (AD) has not been investigated so far. We aimed to evaluate the utility of allergen microarrays in the diagnostic workup of adults with AD and to compare this new diagnostic tool with a conventional method of specific IgE (sIgE) measurement. In sera of 40 atopic adults, sIgE levels detected by microarray-analysis were correlated with the results of an established fluorescence enzyme immunoassay (FEIA). In a further 20 patients with AD, individual sIgE recognition patterns were established by microarray analysis and evaluated with regard to clinical features of AD. Allergen microarray and FEIA results were significantly correlated (r \= 0.72-0.99), especially if recombinant allergens were employed. AD patients revealed a mean of 21 sensitizations per individual (range 1-46) and 65% displayed sIgE against cross-allergens, particularly pathogenesis related proteins such as the major allergen of birch pollen (Bet v 1), alder pollen (Aln g 1), apple (Mal d 1) or celery (Api g 1). The current study provides evidence that allergen microarrays represent a promising tool for component-resolved diagnosis in patients with AD. However, further large-scale studies in unselected patient populations are needed before the introduction of allergen microarrays into daily clinical practice.

Keywords : AD, atopic dermatitis, CRD, component-resolved diagnosis, FEIA, fluorescence enzyme immunoassay, SCORAD, severity scoring of atopic dermatitis index, sIgE, allergen-specific immunoglobulin E, tIgE, total serum immunoglobulin E

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]